SCHEMBL5963970

SCHEMBL5963970

C#CC(C)(C)NS(=O)(=O)Cc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.49
CA2 P00918 2/20 0.49
MMP1 P03956 1/20 0.49
MMP2 P08253 1/20 0.49
MMP9 P14780 1/20 0.49
MMP8 P22894 1/20 0.49
MMP13 P45452 1/20 0.49
ALDH1A1 P00352 6/20 0.42
HPGD P15428 4/20 0.42
KDM4E B2RXH2 3/20 0.42
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41
FAAH O00519 1/20 0.40
PRSS1 P07477 1/20 0.40
PRSS2 P07478 1/20 0.40
ELANE P08246 1/20 0.40
PRTN3 P24158 1/20 0.40
PRSS3 P35030 1/20 0.40
CA5A P35218 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5001293 0.84 KDM4E (0.44) ALDH1A1HPGDKDM4EKMT2AMEN1
SCHEMBL634086 0.80 CA1 (0.57) CA1CA2MMP1MMP2MMP9
SCHEMBL28393150 0.75 ATM (0.50) CA1CA2MMP1MMP2MMP9
SCHEMBL14675961 0.75 CA1 (0.55) CA1CA2MMP1MMP2MMP9
SCHEMBL5963267 0.75 CA1 (0.55) CA1CA2MMP1MMP2MMP9
SCHEMBL20033705 0.73 CA1 (0.49) CA1CA2MMP1MMP2MMP9
SCHEMBL5264576 0.73 CA1 (0.57) CA1CA2MMP1MMP2MMP9
SCHEMBL15438998 0.72 CA1 (0.47) CA1CA2MMP1MMP2MMP9
SCHEMBL3817451 0.72 CA1 (0.47) CA1CA2MMP1MMP2MMP9
SCHEMBL12203604 0.72 CA1 (0.55) CA1CA2MMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7125840-B2 Substituted dipeptides as growth hormone secretagogues ELI LILLY AND COMPANY (US) 2006-10-24 US disclosed
EP-1326851-B1 SUBSTITUTED DIPEPTIDES AS GROWTH HORMONE SECRETAGOGUES LILLY CO ELI (US) 2004-06-30 EP disclosed
US-20040058971-A1 Substituted dipeptides as growth hormone secretagogues ELI LILLY AND COMPANY 2004-03-25 US disclosed
EP-1326851-A1 SUBSTITUTED DIPEPTIDES AS GROWTH HORMONE SECRETAGOGUES ELI LILLY AND COMPANY (US) 2003-07-16 EP disclosed
WO-2002032888-A1 SUBSTITUTED DIPEPTIDES AS GROWTH HORMONE SECRETAGOGUES ELI LILLY AND COMPANY (US) 2002-04-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058971-A1 Substituted dipeptides as growth hormone secretagogues GHSR, GHRHR, SSTR4 CA1 1537/4885CA2 3182/4885MMP1 2096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.